Gene Therapy for Cancer / Edition 1

Hardcover (Print)
Buy New
Buy New from BN.com
$208.94
Used and New from Other Sellers
Used and New from Other Sellers
from $69.55
Usually ships in 1-2 business days
(Save 76%)
Other sellers (Hardcover)
  • All (6) from $69.55   
  • New (5) from $150.72   
  • Used (1) from $69.55   

Overview

The possibility of treating cancer, a disease frequently defined by genetic defects, by introducing genes that target these very alterations has generated tremendous enthusiasm. This enthusiasm, however, has been tempered by an increasing number of obstacles to successful therapy, including vector systems that do not reach systemic metastases, therapeutic genes with redundant mechanisms allowing for cellular resistance, and toxicities in clinical trials that result in premature closure. The three comprehensive sections of this volume present currently available cancer gene therapy techniques, with specific attention to these trouble spots. Part I describes the various aspects of gene delivery including vehicles, or vectors, and their respective characteristics and production methods. In Part II, the contributors discuss strategies and targets for the treatment of cancer, including methods for cell-death therapies, correction of underlying genetic defects at the molecular level, and activation of the immune system or tumor microenvironment. The contributors provide a succinct framework for understanding the basic underlying oncogenic changes, which encourages the development of vectors engineered to exploit these gene mutations through selective spread of the vector in tumor cells with the specific changes. Finally, in Part III, experts in clinical gene therapy trials discuss the difficulties inherent in bringing gene therapy treatment for cancer to the clinic, and principal investigators present gene therapy approache in the clinical testing stage and the results that have reached the stage of clinical testing of these trials. Vectors used in gene therapy for cancer, Characteristicsand production methods of cancer gene vectors, Targets and specific approaches for the therapy of cancer, Clinical applications of cancer gene therapy.
Read More Show Less

Editorial Reviews

From the Publisher
From the reviews:

"The book is divided into 3 sections. … this book is informative and provides a comprehensive review of the advances and limitations of cancer gene therapy. … Overall, the book provides enjoyable and instructive reading material. I highly recommend this book to scientists as well as clinicians as a reference source for cancer gene therapy. Readers would benefit from this excellent reading material, whether they are relatively new to this subspecialty or are actively working within the field of cancer gene therapy." (Prem Seth, JAMA, Vol. 299 (11), 2008)

"Gene Therapy for Cancer … covers the current technologies of cancer gene therapy as well as the difficult task of applying these in clinical trials. … The book also benefits through its helpful tables, drawings and illustrations. … Gene Therapy for Cancer provides a good overview of currently available techniques for cancer gene therapy and their limitations and potential for clinical applications. The book is a useful addition to the library of both researchers and clinicians working in the field." (S. Schepelmann and C. J. Springer, British Journal of Cancer, Vol. 98 (3), 2008)

“This new volume in Humana’s series is written for oncologists, hematologists, cancer researchers, geneticists.” (Tumori, Vol. 93, 2007)

Read More Show Less

Product Details

  • ISBN-13: 9781588294722
  • Publisher: Springer-Verlag New York, LLC
  • Publication date: 2/28/2007
  • Series: Cancer Drug Discovery and Development Series
  • Edition description: 2007
  • Edition number: 1
  • Pages: 469
  • Product dimensions: 7.40 (w) x 10.20 (h) x 0.90 (d)

Table of Contents


Preface     v
Contributors     ix
Vectors
Adenovector-Mediated Cancer Gene Therapy   Bingliang Fang   Jack A. Roth     3
Efficacy, Toxicity, and Immunogenicity of Adenoviral Vectors   Dmitry M. Shayakhmetov     23
Lentiviral and Retroviral Vector Systems   Renata Stripecke   Noriyuki Kasahara     39
Vaccinia and Pox-Virus   Sricharan Chalikonda   David L. Bartlett     73
Herpes Simplex Virus as a Therapy for Cancer   Ian J. Mohr     87
Alphavirus Vectors for Gene Therapy Applications   Kenneth Lundstrom     109
Vesicular Stomatitis Virus and RNA Viruses as Gene Therapy Vectors   Glen N. Barber     121
Parvovirus Vectors   Selvarangan Ponnazhagan     141
Nonviral Vector Systems   Pui-yan Lee   Leaf Huang     157
Gene Therapy Approaches
Oncogenes, Tumor Suppressor Genes, and Apoptosis-Inducing Genes Utilized in Cancer Gene Therapy   Lidong Zhang   Bingliang Fang     173
Gene Silencing Therapy Against Cancer   Chao-Zhong Song     185
Tumor Targeting-Retargeted Adenovirus   Masato Yamamoto   David T. Curiel     197
Oncolytic HerpesSimplex for Gene Therapy in Preclinical and Clinical Trials   Richard H. Pin   Maura Reinblatt   Yuman Fong   William R. Jarnagin     213
Cytokine Gene Therapy for Genitourinary Cancer   Terry L. Timme   Tetsuo Fujita   Hongyu Wang   Koji Naruishi   Dov Kadmon   Robert J. Amato   Brian J. Miles   Gustavo Ayala   Thomas M. Wheeler   Bin S. Teh   E. Brian Butler   Timothy C. Thompson     223
Combination of Gene Therapy with Radiation   Anupama Munshi   Raymond E. Meyn     243
Gene Transfer for Chemoprotection and Enrichment of Hematopoietic Stem Cells   Justin C. Roth   Stanton L. Gerson     257
Nonviral Genetic Vaccines for Cancer   Steven R. Little   Daniel G. Anderson   Robert Langer     281
Gene Therapy Targeted at Angiogenesis and Lymphangiogenesis for Cancer Treatment   Anita T. Tandle   Steven K. Libutti     301
Tumor-Specific Replicating Adenoviruses: [Delta] 24 for Human Gliomas   Giacomo G. Vecil   Juan Fueyo   Frederick F. Lang     331
Clinical Applications
Problems, Side Effects, and Disappointments in Clinical Cancer Gene Therapy   Ta-Chiang Liu    David H. Kirn     351
Trials and Tribulations in Developing Clinical Trials of Gene Therapy: E1A for Breast or Ovarian Cancer   Naoto T. Ueno   Judith K. Wolf   David M. Gershenson   Gabriel N. Hortobagyi   Mien-Chie Hung     387
Phase I Clinical Experience with Intravenous Administration of PV701, an Oncolytic Virus   Andrew L. Pecora   Robert M. Lorence     399
MDA-7/IL-24 as a Multi-Modality Therapy for Cancer   Sunil Chada   Dora Bocangel   Abujiang Pataer   Abner M. Mhashilkar   Satoshi Inoue   Ryo Miyahara   Jack A. Roth   Elizabeth A. Grimm   Stephen G. Swisher   Kelly K. Hunt   Rajagopal Ramesh     413
Development of Therapeutic Genes for Breast Cancer Treatment   Mien-Chie Hung   Duen-Hwa Yan     435
Steps in a Translational Cancer Gene Therapy Trial   Urs W. von Holzen   Stephen G. Swisher     447
Index     461
Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)